FZMD Fuse Medical


Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 9, 2021, Fuse Medical, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”). The total number of shares of common stock eligible to vote as of the record date, April 14, 2021, was 73,124,458 and, pursuant to the Company’s Bylaws, 36,562,230 shares were required to be present or represented at the Annual Meeting to constitute a quorum. The total number of shares of common stock present or represented at the Annual Meeting was 66,190,678, and a quorum therefore existed.

At the Annual Meeting:

1.Election of Board of Directors. The following persons were elected as directors of the Company for a one-year term expiring at the 2022 Annual Meeting of Stockholders with the following vote:


Votes For

Votes Against

Votes Withheld
Renato V. Bosita, Jr., MD64,700,611072,2301,417,837
Mark W. Brooks64,700,642072,1991,417,837
William E. McLaughlin, III64,698,148074,6931,417,837
Christopher C. Reeg64,700,648072,1931,417,837

2.Ratification of the Selection of Armanino LLP (“Armanino”). The selection of Armanino to act as independent registered public accounting firm for the Company for the fiscal year ending December 31, 2021 was ratified by a vote of (i) 66,147,916 in favor, (ii) 42,762 against, and (iii) zero abstaining.